1. Stocks
    2. /
  2. Mesoblast Limited (ASX: MSB)
    3. /

Mesoblast Limited (ASX: MSB) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mesoblast Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Mesoblast Limited (ASX: MSB)
    Latest News

    Person holding Australian dollar notes, symbolising dividends.
    Healthcare Shares

    $1,000 invested in Mesoblast shares at the start of 2024 is now worth…

    | James Mickleboro

    Did this biotech company deliver the goods for investors? Let's see what a $1,000 investment would be worth.

    Read more »

    Excited couple celebrating success while looking at smartphone.
    Healthcare Shares

    Up 19% in a month, what's driving Mesoblast shares?

    | Zach Bristow

    Investors have piled into the stock en masse this past month.

    Read more »

    A financial expert or broker looks worried as he checks out a graph showing market volatility.
    Healthcare Shares

    Mesoblast shares dip then flip on $800,000 insider buy

    | Bronwyn Allen

    The Mesoblast share price is resettling after a near-70% spike in December.

    Read more »

    Man with a hand on his head looks at a red stock market chart showing a falling share price.
    Share Fallers

    Why Mesoblast, Myer, Premier Investments, and Vulcan shares are falling today

    | James Mickleboro

    These shares are having a tough session on Tuesday. But why?

    Read more »

    Shot of a young businesswoman looking stressed out while working in an office.
    Healthcare Shares

    Why is the Mesoblast share price crashing 9% today?

    | James Mickleboro

    What is weighing on this high-flying stock on Tuesday? Let's find out.

    Read more »

    Medical or healthcare workers grasp hands in the universal expression of teamwork
    Healthcare Shares

    Here's how the ASX 200 market sectors stacked up last week

    | Bronwyn Allen

    Healthcare was the strongest sector last week, with market darling Pro Medicus surging yet again.

    Read more »

    Boys making faces and flexing.
    Small Cap Shares

    3 ASX small-cap shares that ripped 295% to 900% in 2024

    | Bronwyn Allen

    Several individual small-caps shone but the S&P/ASX Small Ordinaries Index underperformed the ASX 200.

    Read more »

    A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
    Healthcare Shares

    Why are Mesoblast shares in a trading halt?

    | Bronwyn Allen

    The biotech company requested a trading halt before the market open on Friday. Here's why.

    Read more »

    A group of people at a party look upwards to the camera as they celebrate the rise of ASX value shares
    Share Gainers

    16 ASX shares that doubled in value last year

    | Bronwyn Allen

    There were multiple ASX All Ords stocks that delivered double-or-more share price growth in 2024.

    Read more »

    rising medical asx share price represented by excited doctors dancing in ward
    Healthcare Shares

    Up 77% in a month! What's going on with the Mesoblast share price?

    | Sebastian Bowen

    This stock has blown the lights out in recent weeks...

    Read more »

    A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
    Share Fallers

    Why Brainchip, Fortescue, Mesoblast, and St George Mining shares are falling

    | James Mickleboro

    These shares are having a tough time on Tuesday. Why are investors selling them?

    Read more »

    strong woman overlooking city
    ETFs

    Here's how the Vanguard Australian Shares Index ETF performed in 2024

    | Bronwyn Allen

    Investors in Australia's biggest ASX ETF enjoyed strong returns last year.

    Read more »

    Frequently Asked Questions

    No, Mesoblast does not pay shareholder dividends at this time.

    Yes, Mesoblast is listed on the ASX and the US Nasdaq under the ticker code NASDAQ: MESO.

    Mesoblast Ltd listed on the ASX on 16 December 2004.

    MSB ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Mesoblast Limited

    Mesoblast Ltd (ASX: MSB) is a clinical-stage biotechnology company. It develops and commercialises allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care.

    Its portfolio of Phase 3 product candidates includes its flagship remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) as well as moderate to severe acute respiratory distress syndrome (ARDS). Its other candidates include REVASCOR® for advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. These cell therapy candidates are towards the latter stages of their clinical trial pipelines. 

    Mesoblast has locations in Australia, the United States, and Singapore and is dual-listed on the ASX and the US Nasdaq (NASDAQ: MESO).

    Profile

    since

    Note